Refine
Has Fulltext
- yes (54)
Is part of the Bibliography
- yes (54)
Year of publication
- 2022 (54) (remove)
Document Type
- Journal article (50)
- Doctoral Thesis (4)
Language
- English (54) (remove)
Keywords
- heart failure (6)
- adrenocortical carcinoma (3)
- biomarkers (3)
- myocardial infarction (3)
- ACTH (2)
- C-X-C motif chemokine receptor 4 (2)
- CXCR4 (2)
- Cushing’s syndrome (2)
- Fabry disease (2)
- GFAP (2)
- Herzinfarkt (2)
- SOAT1 (2)
- [68Ga]PentixaFor (2)
- biomarker (2)
- cardiac (2)
- endoradiotherapy (2)
- hypercortisolism (2)
- melanoma (2)
- metabolomics (2)
- miRNA (2)
- neurofilament light chain (2)
- obesity (2)
- radial (2)
- theranostics (2)
- therapy (2)
- troponin (2)
- ACC (1)
- Alzheimer’s dementia (1)
- BET Inhibitor (1)
- BRAF mutation (1)
- BRD4 (1)
- Biomarker (1)
- Brain atrophy (1)
- CMR (1)
- COVID‐19 vaccination (1)
- CRH stimulation test (1)
- Cardiac Antigens (1)
- CardioMEMS™ HF-System (1)
- Chronic heart failure (1)
- Cognitive decline (1)
- Cushing (1)
- Cushing syndrome (1)
- Cushing's (1)
- Cushing's disease (1)
- DIA-MS (1)
- Dialyse (1)
- FGF-pathway (1)
- FGFR (1)
- FGFR-inhibitors (1)
- Fabry Disease (FD) (1)
- Fabry genotype (1)
- Fabry phenotype (1)
- Fibroblastenwachstumsfaktor (1)
- Foxp3 (1)
- GLP-1 (1)
- Gb3 and lyso-Gb3 biomarkers (1)
- Glial fibrillary acidic protein (1)
- HUVEC (1)
- HiGHmed (1)
- IDH1/2 (1)
- Immunreaktion (1)
- JQ1 (1)
- KWIC (1)
- Kardinale Antigene (1)
- Kardiologie (1)
- LND (1)
- LNE (1)
- MRI (1)
- MTL30 (1)
- MUST-Score (1)
- Memory dysfunction (1)
- Mycardiale Heilung (1)
- Myocardial Healing (1)
- Myocardial infarction (1)
- Myokardinfarkt (1)
- Myosin (1)
- NAFLD (1)
- NASH (1)
- Nebennierenrindenkrebs (1)
- NfL (1)
- PET (1)
- RYGB (1)
- Raman micro-spectroscopy (1)
- Rechtsventrikuläre Thrombusbildung (1)
- Regulatorische T-Lymphozyt (1)
- Right ventricular dysfunction (1)
- Rotary EXcitation (REX) (1)
- Roux-en-Y gastric bypass (1)
- SARS‐CoV‐2 infection (1)
- STEMI (1)
- Spironolacton (1)
- T-Cell Specificity (1)
- T-Lymphocytes (1)
- T-Lymphozyten (1)
- T-Zell Spezifität (1)
- T-cells (1)
- T1rho (1)
- T1ρ (1)
- TT\(_{1rho}\) mapping (1)
- T\(_{1P}\) dispersion (1)
- T\(_{1P}\) mapping (1)
- Thrombus (1)
- Tregs (regulatory T cells) (1)
- USP28 (1)
- Vorderwandinfarkt (1)
- Workshop Neue Aspekte zur Linksventrikulären Dysfunktion (1992 : Erbach, Rheingau) (1)
- X-chromosomal inactivation (1)
- [11C]-Choline PET/CT (1)
- [11C]-Methionine (1)
- [177Lu]/[90Y]PentixaTher (1)
- [177Lu]PentixaTher (1)
- [90Y]PentixaTher (1)
- [99mTc]-Sestamibi scan (1)
- adrenal cancer (1)
- adrenal surgery (1)
- adrenalectomia (1)
- adrenocortical adenocarcinoma (1)
- adrenocortical adenoma (1)
- adrenocortical cancer (1)
- adrenocortical development (1)
- adrenocortical tumor (1)
- adrenocortical tumors (1)
- adverse effects (1)
- age (1)
- antiphospholipid syndrome (1)
- anti‐SARS‐CoV‐2‐spike IgG (1)
- astrocytoma (1)
- at-home sampling (1)
- atherosclerosis (1)
- blood pressure (1)
- buparlisib (1)
- c-MYC (1)
- cardiac MRI (1)
- cardiac implants (1)
- cardiac magnetic resonance imaging (1)
- cardiac thrombi (1)
- cardiac training group (1)
- cardiomyopathy (1)
- cardiovascular diseases (1)
- cardiovascular drugs (1)
- cardiovascular genetics (1)
- cardiovascular risk factors (1)
- cholesterol metabolism (1)
- chronic kidney disease (1)
- clinical routine data (1)
- cognitive impairment (1)
- coherent anti-Stokes Raman scattering (CARS) microscopy (1)
- complication (1)
- confounders (1)
- correction (1)
- cortisol (1)
- cytochrome P450 3A4 (CYP3A4) (1)
- dabrafenib (1)
- desmin (1)
- diagnosis (1)
- diagnosis in Fabry disease (1)
- drug interaction (1)
- drug intoxication (1)
- drug monitoring (1)
- drug toxicity (1)
- drug–drug interactions (DDIs) (1)
- echocardiography (1)
- ectopic (1)
- efficacy (1)
- endocrine cancer (1)
- endogenous hypercortisolism (1)
- endothelial (1)
- eosinophils (1)
- epithelial to mesenchymal transition (1)
- extended matching questions (1)
- female Fabry patients (1)
- fibroblast growth factors (1)
- fibrosis (1)
- filamin-C (1)
- focused surgical approach (1)
- functional magnetic resonance imaging (1)
- gastric bypass (1)
- gefitinib (1)
- gene variant (1)
- genotype/phenotype correlation (1)
- glial damage (1)
- glial fibrillary acidic protein (1)
- glioblastoma (1)
- graft versus host disease (1)
- haemodialysis (1)
- healthcare workers (1)
- heart (1)
- heart failure training group (1)
- high dose dexamethasone suppression test (1)
- hydroxy-dabrafenib (1)
- hypertension (1)
- immunohistochemistry (1)
- infarction size (1)
- inflammation (1)
- intragastric balloon (1)
- ischemic stroke (1)
- isturisa (1)
- lactic acidosis (1)
- left ventricular ejection fraction (1)
- left ventricular performance (1)
- left ventricular thrombus (1)
- linksventrikulärer Thrombus (1)
- lipid droplets (1)
- liraglutide (1)
- lncRNA (1)
- lung cancer (1)
- lymph node dissection (1)
- lymphadenectomy (1)
- lysosomal storage disease (1)
- m exercise training (1)
- machine learning (1)
- malnutrition (1)
- mapping (1)
- medical data integration center (1)
- medical informatics initiative (1)
- medical students (1)
- medical therapy (1)
- medullary thyroid cancer (1)
- meta-analysis (1)
- metyrapone (1)
- mice (1)
- mitochondria function and morphology (1)
- mitotane (1)
- multi-tyrosine kinase inhibitor (1)
- multicenter (1)
- multiple choice questions (1)
- multiple myeloma (1)
- multivariate data analysis (1)
- myocardial work (1)
- neuroblastoma – diagnosis (1)
- nutritional counseling (1)
- nutritional medical needs (1)
- nutritional risk screening (1)
- oncology outpatients (1)
- openEHR (1)
- oscillating biomagnetic fields (1)
- osilodrostat (1)
- outcome (1)
- oxidative stress (1)
- parathyroid adenoma (1)
- pediatric (1)
- pediatric adrenocortical cancer (1)
- pediatric adrenocortical carcinoma (1)
- pediatric adrenocortical tumor (1)
- peptide tyrosine tyrosine (PYY) (1)
- peptide tyrosine tyrosine 3-36 (PYY\(_{3-36}\)) (1)
- personalised medicine (1)
- pharmacokinetics (1)
- pheochromocytoma/paraganglioma (1)
- phosphorylated tau protein (1)
- physiologically based pharmacokinetic (PBPK) modeling (1)
- pituitary (1)
- plasma NMR (1)
- population pharmacokinetics (1)
- posaconazole (1)
- preanalytical conditions (1)
- precision medicine (1)
- primary aldosteronism (1)
- primary hyperparathyroidism (1)
- prognosis (1)
- prognostic markers (1)
- prostate cancer (1)
- proteomic (1)
- pulmonary artery pressure (1)
- quantitative MRI (1)
- radiotherapy (1)
- randomized controlled trial (1)
- rearranged during transfection (1)
- remote monitoring (1)
- renal function (1)
- restrictive cardiomyopathy (1)
- review (1)
- risk prediction scores (1)
- ruxolitinib (1)
- semantic interoperability (1)
- seroprevalence (1)
- sex differences (1)
- shear stress (1)
- short-chain fatty acids (1)
- signal voids (1)
- sleeve gastrectomy (1)
- small animal (1)
- spin lock (1)
- spin-lock (1)
- spironolactone (1)
- super-obesity (1)
- survival (1)
- targeted therapy (1)
- targeted treatment (1)
- trametinib (1)
- treatment (1)
- treatment outcome (1)
- uremic toxins (1)
- variant (1)
- vemurafenib (1)
- volume (1)
- volumetric absorptive micro-sampling (VAMS) (1)
Institute
- Medizinische Klinik und Poliklinik I (54) (remove)
Sonstige beteiligte Institutionen
Our current data demonstrate that besides the known risk factors, including apical aneurysm, reduced left ventricular longitudinal systolic function (MAPSE) and advanced diastolic dysfunction, Right ventricular dysfunction as determined by reduced tricuspid annular plane systolic excursion (TAPSE) or right ventricular fractional area change (RV_FAC) is independently associated with left ventricular thrombus formation in acute anterior myocardial infarction patients, especially in the setting of anterior myocardial infarction without the formation of an apical aneurysm. This study suggests that besides left ventricular abnormalities, right ventricular dysfunction likewise contributes LVT formation in patients with acute anterior myocardial infarction.
(1) Background: Locoregional lymphadenectomy (LND) in adrenocortical carcinoma (ACC) may impact oncological outcome, but the findings from individual studies are conflicting. The aim of this systematic review and meta-analysis was to determine the oncological value of LND in ACC by summarizing the available literature. (2) Methods: A systematic search on studies published until December 2020 was performed according to the PRISMA statement. The primary outcome was the impact of lymphadenectomy on overall survival (OS). Two separate meta-analyses were performed for studies including patients with localized ACC (stage I–III) and those including all tumor stages (I–IV). Secondary endpoints included postoperative mortality and length of hospital stay (LOS). (3) Results: 11 publications were identified for inclusion. All studies were retrospective studies, published between 2001–2020, and 5 were included in the meta-analysis. Three studies (N = 807 patients) reported the impact of LND on disease-specific survival in patients with stage I–III ACC and revealed a survival benefit of LND (hazard ratio (HR) = 0.42, 95% confidence interval (95% CI): 0.26–0.68). Based on results of studies including patients with ACC stage I–IV (2 studies, N = 3934 patients), LND was not associated with a survival benefit (HR = 1.00, 95% CI: 0.70–1.42). None of the included studies showed an association between LND and postoperative mortality or LOS. (4) Conclusion: Locoregional lymphadenectomy seems to offer an oncologic benefit in patients undergoing curative-intended surgery for localized ACC (stage I–III).
Cardiovascular diseases (CVD), subsuming atherosclerosis of the coronary arteries and subsequent myocardial infarction, are the leading cause of death in the European Union (over 4 million deaths annually), with devastating individual and economic consequences.
Recent studies revealed that T cells play a crucial role in post-MI inflammation, healing and remodelling processes. Nevertheless, the specificity profile of adaptive immune responses in the infarcted myocardium has not yet been differentiated. The experiments portrayed in this thesis sought to assess whether post-MI CD4+ T cell responses in mice are triggered by heart specific antigens, and eventually identify relevant epitopes.
We were able to create a murine antigen atlas including a list of 206 epitopes for I-Ab and 193 epitopes for I-Ad presented on MHC-II in the context of MI. We sought to consecutively test this panel by in vitro T cell proliferation and antigen recall assays ex vivo. The elispot assay was used as a readout for antigen-specific stimulation by measurement of IL-2 and IFN-γ production, currently the most sensitive approach available to detect even small counts of antigen producing cells. Splenocytes as well as lymphocytes from mediastinal lymph nodes were purified from animals 7 days or 56 days after EMI conducted by ligation of the left anterior descending artery.
We were able to provide evidence that post-MI T cell responses in Balb/c mice are triggered by heart-specific antigens and that MYHCA, especially MYHCA614-628, is relevant for that response. Moreover, a significant specific T cell response after MI in C57BL/6J mice was observed for α actin, cardiac muscle 1 [ACTC1], myosin-binding protein C3 [MYBPC3] and myosin heavy chain α [MYHCA] derived heart specific antigens.
Generally, the epitopes of interest for Balb/c as well as C57BL/6J could be further investigated and may eventually be modulated in the future.
Spin-lock based functional magnetic resonance imaging (fMRI) has the potential for direct spatially-resolved detection of neuronal activity and thus may represent an important step for basic research in neuroscience. In this work, the corresponding fundamental effect of Rotary EXcitation (REX) is investigated both in simulations as well as in phantom and in vivo experiments. An empirical law for predicting optimal spin-lock pulse durations for maximum magnetic field sensitivity was found. Experimental conditions were established that allow robust detection of ultra-weak magnetic field oscillations with simultaneous compensation of static field inhomogeneities. Furthermore, this work presents a novel concept for the emulation of brain activity utilizing the built-in MRI gradient system, which allows REX sequences to be validated in vivo under controlled and reproducible conditions. Via transmission of Rotary EXcitation (tREX), we successfully detected magnetic field oscillations in the lower nano-Tesla range in brain tissue. Moreover, tREX paves the way for the quantification of biomagnetic fields.
Testing based on multiple choice questions (MCQ) is one of the most established forms of assessment, not only in the medical field. Extended matching questions (EMQ) represent a specific type of MCQ designed to require higher levels of cognition, such as problem-solving. The purpose of this evaluation was to assess the suitability and efficiency of EMQ as an assessment method. EMQ were incorporated into the end-of-semester examination in internal medicine, in which 154 students participated, and compared with three established MCQ types. Item and examination quality were investigated, as well as readability and processing time. EMQ were slightly more difficult to score; however, both item discrimination and discrimination index were higher when compared to other item types. EMQ were found to be significantly longer and required more processing time, but readability was improved. Students judged EMQ as clearly challenging, but attributed significantly higher clinical relevance when compared to established MCQ formats. Using the Spearman-Brown prediction, only ten EMQ items would be needed to reproduce the Cronbach’s alpha value of 0.75 attained for the overall examination. EMQ proved to be both efficient and suitable when assessing medical students, demonstrating powerful characteristics of reliability. Their expanded use in favor of common MCQ could save examination time without losing out on statistical quality.
Background
Fast and accurate T1ρ mapping in myocardium is still a major challenge, particularly in small animal models. The complex sequence design owing to electrocardiogram and respiratory gating leads to quantification errors in in vivo experiments, due to variations of the T\(_{1p}\) relaxation pathway. In this study, we present an improved quantification method for T\(_{1p}\) using a newly derived formalism of a T\(_{1p}\)\(^{*}\) relaxation pathway.
Methods
The new signal equation was derived by solving a recursion problem for spin-lock prepared fast gradient echo readouts. Based on Bloch simulations, we compared quantification errors using the common monoexponential model and our corrected model. The method was validated in phantom experiments and tested in vivo for myocardial T\(_{1p}\) mapping in mice. Here, the impact of the breath dependent spin recovery time T\(_{rec}\) on the quantification results was examined in detail.
Results
Simulations indicate that a correction is necessary, since systematically underestimated values are measured under in vivo conditions. In the phantom study, the mean quantification error could be reduced from − 7.4% to − 0.97%. In vivo, a correlation of uncorrected T\(_{1p}\) with the respiratory cycle was observed. Using the newly derived correction method, this correlation was significantly reduced from r = 0.708 (p < 0.001) to r = 0.204 and the standard deviation of left ventricular T\(_{1p}\) values in different animals was reduced by at least 39%.
Conclusion
The suggested quantification formalism enables fast and precise myocardial T\(_{1p}\) quantification for small animals during free breathing and can improve the comparability of study results. Our new technique offers a reasonable tool for assessing myocardial diseases, since pathologies that cause a change in heart or breathing rates do not lead to systematic misinterpretations. Besides, the derived signal equation can be used for sequence optimization or for subsequent correction of prior study results.
Background
Chronic heart failure (HF) is known to increase the risk of developing Alzheimer’s dementia significantly. Thus, detecting and preventing mild cognitive impairment, which is common in patients with HF, is of great importance. Serum biomarkers are increasingly used in neurological disorders for diagnostics, monitoring, and prognostication of disease course. It remains unclear if neuronal biomarkers may help detect cognitive impairment in this high-risk population. Also, the influence of chronic HF and concomitant renal dysfunction on these biomarkers is not well understood.
Methods
Within the monocentric Cognition.Matters-HF study, we quantified the serum levels of phosphorylated tau protein 181 (pTau) and neurofilament light chain (NfL) of 146 extensively phenotyped chronic heart failure patients (aged 32 to 85 years; 15.1% women) using ultrasensitive bead-based single-molecule immunoassays. The clinical work-up included advanced cognitive testing and cerebral magnetic resonance imaging (MRI).
Results
Serum concentrations of NfL ranged from 5.4 to 215.0 pg/ml (median 26.4 pg/ml) and of pTau from 0.51 to 9.22 pg/ml (median 1.57 pg/ml). We detected mild cognitive impairment (i.e., T-score < 40 in at least one cognitive domain) in 60% of heart failure patients. pTau (p = 0.014), but not NfL, was elevated in this group. Both NfL (ρ = − 0.21; p = 0.013) and pTau (ρ = − 0.25; p = 0.002) related to the cognitive domain visual/verbal memory, as well as white matter hyperintensity volume and cerebral and hippocampal atrophy. In multivariable analysis, both biomarkers were independently influenced by age (T = 4.6 for pTau; T = 5.9 for NfL) and glomerular filtration rate (T = − 2.4 for pTau; T = − 3.4 for NfL). Markers of chronic heart failure, left atrial volume index (T = 4.6) and NT-proBNP (T = 2.8), were further cardiological determinants of pTau and NfL, respectively. In addition, pTau was also strongly affected by serum creatine kinase levels (T = 6.5) and ferritin (T = − 3.1).
Conclusions
pTau and NfL serum levels are strongly influenced by age-dependent renal and cardiac dysfunction. These findings point towards the need for longitudinal examinations and consideration of frequent comorbidities when using neuronal serum biomarkers.
Against the background of the current COVID-19 infection dynamics with its rapid spread of SARS-CoV-2 variants of concern (VOC), the immunity and the vaccine prevention of healthcare workers (HCWs) against SARS-CoV-2 continues to be of high importance. This observational cross-section study assesses factors influencing the level of anti-SARS-CoV-2-spike IgG after SARS-CoV-2 infection or vaccination. One thousand seven hundred and fifty HCWs were recruited meeting the following inclusion criteria: age ≥18 years, PCR-confirmed SARS-CoV-2 infection convalescence and/or at least one dose of COVID-19 vaccination. anti-SARS-CoV-2-spike IgG titers were determined by SERION ELISA agile SARS-CoV-2 IgG. Mean anti-SARS-CoV-2-spike IgG levels increased significantly by number of COVID-19 vaccinations (92.2 BAU/ml for single, 140.9 BAU/ml for twice and 1144.3 BAU/ml for threefold vaccination). Hybrid COVID-19 immunized respondents (after infection and vaccination) had significantly higher antibody titers compared with convalescent only HCWs. Anti-SARS-CoV-2-spike IgG titers declined significantly with time after the second vaccination. Smoking and high age were associated with lower titers. Both recovered and vaccinated HCWs presented a predominantly good humoral immune response. Smoking and higher age limited the humoral SARS-CoV-2 immunity, adding to the risk of severe infections within this already health impaired collective.
Chronic Kidney Disease (CKD) is a debilitating disease associated with several secondary complications that increase comorbidity and mortality. In patients with CKD, there is a significant qualitative and quantitative alteration in the gut microbiota, which, consequently, also leads to reduced production of beneficial bacterial metabolites, such as short-chain fatty acids. Evidence supports the beneficial effects of short-chain fatty acids in modulating inflammation and oxidative stress, which are implicated in CKD pathogenesis and progression. Therefore, this review will provide an overview of the current knowledge, based on pre-clinical and clinical evidence, on the effect of SCFAs on CKD-associated inflammation and oxidative stress.
Background
Troponin elevation is common in ischemic stroke (IS) patients. The pathomechanisms involved are incompletely understood and comprise coronary and non-coronary causes, e.g. autonomic dysfunction. We investigated determinants of troponin elevation in acute IS patients including markers of autonomic dysfunction, assessed by heart rate variability (HRV) time domain variables.
Methods
Data were collected within the Stroke Induced Cardiac FAILure (SICFAIL) cohort study. IS patients admitted to the Department of Neurology, Würzburg University Hospital, underwent baseline investigation including cardiac history, physical examination, echocardiography, and blood sampling. Four HRV time domain variables were calculated in patients undergoing electrocardiographic Holter monitoring. Multivariable logistic regression with corresponding odds ratios (OR) and 95% confidence intervals (CI) was used to investigate the determinants of high-sensitive troponin T (hs-TnT) levels ≥14 ng/L.
Results
We report results from 543 IS patients recruited between 01/2014–02/2017. Of those, 203 (37%) had hs-TnT ≥14 ng/L, which was independently associated with older age (OR per year 1.05; 95% CI 1.02–1.08), male sex (OR 2.65; 95% CI 1.54–4.58), decreasing estimated glomerular filtration rate (OR per 10 mL/min/1.73 m2 0.71; 95% CI 0.61–0.84), systolic dysfunction (OR 2.79; 95% CI 1.22–6.37), diastolic dysfunction (OR 2.29; 95% CI 1.29–4.02), atrial fibrillation (OR 2.30; 95% CI 1.25–4.23), and increasing levels of C-reactive protein (OR 1.48 per log unit; 95% CI 1.22–1.79). We did not identify an independent association of troponin elevation with the investigated HRV variables.
Conclusion
Cardiac dysfunction and elevated C-reactive protein, but not a reduced HRV as surrogate of autonomic dysfunction, were associated with increased hs-TnT levels in IS patients independent of established cardiovascular risk factors.